More articles about Infectious Disease

The test is based on the company's portable diagnostic platform and can qualitatively detect Zika RNA in human serum.

The UK-based firm is selling technology underlying its point-of-care molecular diagnostics platform, the Enigma MiniLab.

Curetis' new subsidiary will focus on using a recently acquired database of bacterial genome sequences to identify novel antibiotic resistance markers. 

While point-of-care molecular testing of patients with respiratory illness wasn't associated with lower antibiotic use, patients tested had shorter drug courses.

Adaptive aims to commercialize and scale its techniques to identify immune signatures in other infectious diseases, autoimmune disorders, and even cancer.

The deal covers Mobidiag's full line of Amplidiag tests for gastrointestinal infections, as well as the high-throughput Amplidiag Easy system.

The test adds to the firm's current portfolio of 30 infectious disease and oncology tests that use its Sentosa PCR and NGS workflow.

The PREDICT/PDF-2180 virus is the latest coronavirus identified in a bat species, supporting a potential bat reservoir role in the evolution of such viruses.

The Liat point of care system system has launched with four assays, including three respiratory tests and a novel test for Clostridium difficile.

The test, which runs directly from a patient nasopharyngeal swab, is the fifth assay on the firm's sample-to-result molecular diagnostics platform.

The Bay Area firm is planning to launch a low-cost, microfluidics-based infectious disease diagnostic called the Simple Chip in the next few years. 

The method uses graphene-coated silica particles fused to complementary RNA to register impedance changes in the presence of viruses.

The company has also developed software that will enable automated melt curve analysis on Cepheid's existing GeneXpert platforms.

The test for cervical cancer screening previously received the IVD mark and US Food and Drug Administration approval on the Cobas 4800 system.

The semifinalists will receive $50,000 each to develop prototypes of their concepts for submission in the second phase of the challenge.

The company said that changes it made in the fourth quarter, including a recently announced restructuring plan, will lead to improvements in 2017.

Researchers sequenced and analyzed 169 Mycobacterium tuberculosis strains from people with and without HIV infections.

The firm said the assay provides flexible automation and accurately identifies all six HCV genotypes as well as subtypes 1a and 1b.

The firm said that the technologies it has licensed improve PCR and RT-PCR amplification of DNA and RNA.

Researchers described a vancomycin-resistant Enterococcus infection transmitted from a liver donor to recipient, ruling out hospital-acquired infection with genomics.

Pages

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.